0940-06-01-.03
Controlled Substances In Schedule Iii
Cite as Tenn. Comp. R. & Regs. 0940-06-01-.03
(1)
Schedule III consists of the drugs and other substances by whatever official name, common
or usual name, chemical name, or brand name designated, listed in this rule. Each drug or
substance bears the federal controlled substance code number assigned to it by the Drug
Enforcement Administration.
(2)
Stimulants. Unless specifically excepted or unless listed in another schedule, any material,
compound, mixture, or preparation which contains any quantity of the following substances
having a stimulant effect on the central nervous system, including its salts, isomers (whether
optical, position or geometric), and salts of such isomers whenever the existence of such
salts, isomers, and salts of isomers is possible within the specific chemical designation:
(a)
Those compounds, mixtures, or preparations in dosage unit form containing any
stimulant substances listed in Schedule II which compounds, mixtures, or preparations
were listed on August 25, 1971, as excepted compounds under 21 C.F.R. 1308.32, and
any other drug of the quantitative composition shown in that list for those drugs or
which is the same except that it contains a lesser quantity of controlled substances……
……………………………………………………………………………………………….1405
(b)
Benzphetamine
…………………………………………………………………………. 1228
(c)
Clorphentermine ………………………………………………………………………….1645
(d)
Clortermine ………………………………………………………………………………… 1647
(e)
Phendimetrazine ………………………………………………………………………….1615
(3)
Depressants. Unless specifically excepted or unless listed in another schedule, any material,
compound, mixture, or preparation which contains any quantity of the following substances
having a depressant effect in the central nervous system:
(a)
Any compound, mixture, or preparation containing:
1.
Amobarbital …….………………………………………………………………….. 2126
2.
Secobarbital……..…………………………………………………………………. 2316
3.
Pentobarbital…….………………………………………………………………….. 2271
Or any salt thereof and one or more other active medicinal ingredients which are
not listed in any schedule.
(b)
Any suppository dosage form containing:
1.
Amobarbital …….………………………………………………………………….. 2126
2.
Secobarbital…….………………………………………………………………….. 2316
CONTROLLED SUBSTANCES
CHAPTER 0940-06-01
3.
Pentobarbital…….………………………………………………………………….. 2271
Or any salt of these drugs and approved by the Food and Drug Administration for
marketing only as a suppository.
(c)
Any substance which contains any quantity of a derivative of barbituric acid or any salt
thereof. Examples include the following drugs………………………………………… 2100
1.
Aprobarbital …….…………………………………………………………………. 2100
2.
Butabarbital (secbutabarbital) …….……………………………………………. 2100
3.
Butalbital…….…………………………………………………………………..….. 2100
4.
Butobarbital (butethal) …….…………………………………………………..….. 2100
5.
Talbutal…….………………………………………………………………………. 2100
6.
Thiamylal…….…………………………………………………………………….. 2100
7.
Thiopental…….…………………………………………………………………….. 2100
8.
Vinbarbital…….…………………………………………………………………….. 2100
(d)
Chlorhexadol…….………………………………………………………………………. 2510
(e)
Embutramide…….…………………………………………………………………….….. 2020
(f)
Gamma hydroxybutyric acid preparations. Any drug product containing gamma
hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an
application is approved under § 505 of the federal Food, Drug, and Cosmetic Act,
codified in 21 U.S.C. §§ 301, et seq…….……….……………………………………. 2012
(g)
Ketamine, its salts, isomers, and salts of isomers ……………………………………..7285
Other name: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone
(h)
Lysergic acid…….……………………………………………………………………..….. 7300
(i)
Lysergic acid amide…….…………………………………………………………….….. 7310
(j)
Methyprylon…….………………………………………………………………………….. 2575
(k)
Perampanel, and its salts, isomers, and salts of isomers…………………………….. 2261
(l)
Sulfondiethylmethane…….………………………………………………………………..2600
(m)
Sulfonethylmethane…….……………………………………………………………..….. 2605
(n)
Sulfonmethane…….…………………………………………………………………….. 2610
(o)
Tiletamine and zolazepam or any salt of tiletamine or zolazepam…………………. 7295
1.
Other name for a tiletamine-zolazepam combination product: Telazol®.
2.
Other name for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone.
CONTROLLED SUBSTANCES
CHAPTER 0940-06-01
3.
Other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-
trimethylpyrazolo[3,4-e],[1,4]-diazepin-7(1H)-one; flupyrazapon.
(4)
Nalorphine…….…………………………………………………………………………………… 9400
(5)
Narcotic Drugs.
(a)
Unless specifically excepted or unless listed in another schedule, any material,
compound, mixture, or preparation containing any of the following narcotic drugs, or
their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set
forth below:
1.
Not more than 8 grams of codeine per 100 milliliters or not more than 90
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
alkaloid of opium…………………………………………………………………… 9803
2.
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
milligrams per dosage unit, with one or more active, non-narcotic ingredients in
recognized therapeutic amounts……………………………………………..….. 9804
3.
Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than
90 milligrams per dosage unit with one or more active non-narcotic ingredients in
recognized therapeutic amounts………………………………………….…..…. 9807
4.
Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
than 15 milligrams per dosage unit with one or more active non-narcotic
ingredients in recognized therapeutic amounts……………………………..…. 9808
5.
Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not
more than 25 milligrams per dosage unit, with one or more active, non-narcotic
ingredients in recognized therapeutic amounts……………………….……….. 9809
6.
Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams,
with one or more active, non-narcotic ingredients in recognized therapeutic
amounts…………………………………………………….…………………….... 9810
(b)
Any material, compound, mixture, or preparation containing any of the following
narcotic drugs or their salts:
1.
Buprenorphine…………………………………………………………….…..…… 9064
(6)
Anabolic steroids. Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation containing any quantity of the following
substances, including its salts, esters and ethers:
(a)
Anabolic steroids………………………………………………………………………….. 4000
1.
3[alpha],17[beta]-dihydroxy-5a-androstane
2.
17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5a-androstane
3.
17[alpha]-methyl-3[beta],17[beta]-dihydroxy-5a-androstane
4.
17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene
CONTROLLED SUBSTANCES
CHAPTER 0940-06-01
5.
17[alpha]-methyl-[delta]1-dihydrotestosterone(17[beta]-hydroxy-17[alpha]-methyl-
5[alpha]- androst-1-en-3-one)
Other name: 17-[alpha]-methyl-1-testosterone
6.
17[alpha]-methyl-4-hydroxynandrolone(17[alpha]-methyl-4-hydroxy-17[beta]-
hydroxyestr-4-en-3-one)
7.
1-Androstenediol (3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene)
8.
1-Androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-1-ene)
9.
4-Androstenediol (3[beta],17[beta]-dihydroxy-androst-4-ene)
10.
5-Androstenediol (3[beta],17[beta]-dihydroxy-androst-5-ene)
11.
1-Androstenedione (5[alpha]-androst-1-en-3,17-dione)
12.
4-Androstenedione (androst-4-en-3,17-dione)
13.
5-Androstenedione (androst-5-en-3,17-dione)
14.
3[Beta],17[Beta]-dihydroxy-5a-androstane
15.
13[Beta]-ethyl-17[beta]-hydroxygon-4-en-3-one
16.
Androstanedione (5[alpha]-androstan-3,17-dione)
17.
Bolasterone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one)
18.
Boldenone (17[beta]-hydroxyandrost-1,4-diene-3-one)
19.
Boldione (androsta-1,4-diene-3,17-dione)
20.
Calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one)
21.
Clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one)
Other name: 4-Chlorotestosterone
22.
Dehydrochloromethyltestosterone (4-chloro-17[beta]-hydroxy-17[alpha]-
methylandrost-1,4-dien-3-one)
23.
[Delta]1-dihydrotestosterone (a.k.a. ‘1-testosterone’) (17[Beta]-hydroxy-5[alpha]-
androst-1-en-3-one)
24.
Desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[Beta]-ol)
Other name: madol
25.
4-Dihydrotestosterone (17[beta]-hydroxyandrostan-3-one)
26.
Drostanolone (17[beta]-hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one)
27.
Ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene)
28.
Fluoxymesterone (9-fluoro-17[alpha]-methyl-11[beta],17[beta]-dihydroxyandrost-
4-en-3-one)
CONTROLLED SUBSTANCES
CHAPTER 0940-06-01
29.
Formebolone (2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-
1,4-dien-3-one)
30.
Furazabol (17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan)
31.
4-Hydroxy-19-nortestosterone (4,17[beta]-dihydroxyestr-4-en-3-one)
32.
4-Hydroxytestosterone (4,17[beta]-dihydroxyandrost-4-en-3-one)
33.
Mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one)
34.
Mesterolone (1[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one)
35.
Methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-diene-3-one)
36.
Methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene)
37.
Methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one)
38.
Methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one)
39.
Methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one)
40.
Methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one)
41.
Methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4, 9,11-trien-3-one)
42.
Mibolerone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyestr-4-en-3-one)
43.
Nandrolone (17[beta]-hydroxyestr-4-en-3-one)
44.
19-Nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)
45.
19-Nor-4-androstenediol (3[alpha],17[beta]-dihydroxyestr-4-ene)
46.
19-Nor-4-androstenediol (3[beta],17[beta]-dihydroxyestr-4-ene)
47.
19-Nor-5-androstenediol (3[alpha],17[beta]-dihydroxyestr-5-ene)
48.
19-Nor-5-androstenediol (3[beta],17[beta]-dihydroxyestr-5-ene)
49.
19-Nor-4-androstenedione (estr-4-en-3,17-dione)
50.
19-Nor-5-androstenedione (estr-5-en-3,17-dione)
51.
Norbolethone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one)
52.
Norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one)
53.
Norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one)
54.
Normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one)
55.
Oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-
one)
CONTROLLED SUBSTANCES
CHAPTER 0940-06-01
56.
Oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one)
57.
Oxymetholone (17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-
[5[alpha]]-androstan-3-one)
58.
Prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pryazole)
59.
Stanozolol (17[alpha]-methyl-17[beta]-hydroxy-[5[alpha]]-androst-2-eno[3,2-c]-
pyrazole)
60.
Stenbolone (17[beta]-hydroxy-2-methyl-[5[alpha]]-androst-1-en-3-one)
61.
Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1, 4-dien-17-oic acid
lactone)
62.
Testosterone (17[beta]-hydroxyandrost-4-en-3-one)
63.
Tetrahydrogestrinone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4, 9,11-
trien-3-one)
64.
Trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one)
(b)
Any salt, ester, or isomer of a drug or substance described or listed in subparagraph
(a), if such salt, ester, or isomer promotes muscle growth.
(c)
Anabolic steroids intended for administration to cattle or other non-human species are
exempt from this rule unless such steroids are prescribed, dispensed, or distributed for
human use.
(d)
Anabolic steroids with a combination of estrogens intended for administration to
hormone deficient women are exempt from this rule unless such steroids are
prescribed, dispensed, or distributed to women who are not hormone deficient.
(7)
Hallucinogenic Substances
(a)
Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
United States Food and Drug Administration approved drug product……………… 7369
Other names: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo
[b,d]pyran-1-ol or (-)-delta-9-(trans) tetrahydrocannabinol